Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

53.12 -2.03 (-3.68%)
Streaming Delayed Price Updated: 10:22 AM EST, Dec 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,470,449
Open 54.50
Bid (Size) 53.09 (7)
Ask (Size) 53.13 (8)
Prev. Close 55.15
Today's Range 52.77 - 54.84
52wk Range 52.71 - 83.25
Shares Outstanding 1,319,574,744
Dividend Yield 5.01%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What the Options Market Tells Us About CVS Health
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga

Performance

YTD
-34.30%
-34.30%
1 Month
-4.82%
-4.82%
3 Month
-6.71%
-6.71%
6 Month
-11.47%
-11.47%
1 Year
-27.98%
-27.98%

More News

Read More
What’s Behind These 3 Recent Analyst Stock Upgrades?
Via MarketBeat
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 7
Via Talk Markets
Topics Stocks / Equities
Blue Shield's $500 Million Drug Savings Initiative With Amazon Pharmacy Can Potentially Launch In January
Via Benzinga
Key Takeaways From CVS Health Analyst Ratings
Via Benzinga
Is CVS Health Stock a Buy?
Via The Motley Fool
CVS Health's Options: A Look at What the Big Money is Thinking
Via Benzinga
UnitedHealthcare Faces Scrutiny Amid CEO's Tragic Death, Industry Criticism
Via Benzinga
13 Healthcare Sector Stocks With Healthy Valuation
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
Via Investor's Business Daily
This Citigroup Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
Via Benzinga
Topics Cannabis
Exposures Cannabis
(CVS) - Analyzing CVS Health's Short Interest
Via Benzinga
Is CVS Health Stock an Underrated Buy?
Via The Motley Fool
CVS Health Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
3 Key Analyst Upgrades: Why These Stocks Are Getting a Boost
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too?
Via The Motley Fool
Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A 'Primetime' Year For AI
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
Via Benzinga
Analyst Expectations For CVS Health's Future
Via Benzinga
Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex'
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
Via Benzinga
1 Great Reason to Buy Realty Income and Hold It Forever
Via The Motley Fool
CVS Health Stock Is Moving Higher Monday: What's Going On?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.